FDA approves Aqvesme (mitapivat) for the treatment of anemia in adults with alpha or beta-thalassemia – Agios Pharmaceuticals
Agios Pharmaceuticals, Inc. announced that the FDA has approved Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for the treatment of anemia in adults with alpha- or beta-thalassemia…. read more.
